Cash, cash equivalents, and short-term marketable securities (Tables)

12 Months Ended

Dec. 31, 2024

Cash and Cash Equivalents [Abstract]

Schedule of Restricted Cash

The following table summarizes the Company's cash, cash equivalents, and restricted cash as of December 31, 2024 and 2023.

(in thousands)	Year Ended December 31, 2024				Year Ended December 31, 2023
	Beginning of period		End of period		Beginning of period		End of period
Cash and cash equivalents	$	174,561	$	107,750	$	128,885	$	174,561
Restricted cash included in other assets, noncurrent	478		478		478		478
Total cash, cash equivalents and restricted cash per statement of cash flows	$	175,039	$	108,228	$	129,363	$	175,039

Schedule of Marketable Securities

The following table summarizes the Company's marketable securities held at December 31, 2024 and 2023.

	December 31, 2024
(in thousands)	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Marketable securities
U.S. treasury securities	$	26,860	$	10	$	—	$	26,870

	December 31, 2023
(in thousands)	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
Marketable securities
U.S. treasury securities	$	29,535	$	13	$	—	$	29,548
U.S. government agency securities	4,977		—		(2)		4,975
Total	$	34,512	$	13	$	(2)	$	34,523